Large epidemiological data demonstrate that CKM multimorbidity affects up to 40% of adults in developed countries and accounts for a substantial proportion of global cardiovascular deaths
Your treatment goals (e.g., blood sugar control, weight loss, and cardiovascular protection)
However, reports and studies have suggested potential links between these medications and several serious complications in some individuals: GLP-1 agonists have been associated with an increased risk of pancreatitis
Completion of Baseline nutritional Assessment and Screening Prior to GLP-1 initiation, all individuals should undergo medical and nutritional assessment and screening (Table 5)
All state Medicaid programs cover the drugs for Type 2 diabetes, but only 14 provide some form of coverage to treat obesity
found that intraperitoneal injection of exendin-4 increased the number of BrdU-positive progenitor cells in the subventricular zone (33), indicating that exendin-4 could compensate for the loss of dopaminergic neurons in the PD model by promoting the formation of substantia nigra neurons
